Can Another Chinese Hospital Use My Test Results?

China Medical Index · Reviewed and last checked 2026-09-09

Sometimes—but never assume that a previous MRI, CT, ultrasound, or laboratory result will automatically be accepted.

China has a national policy framework for mutual recognition of medical examination and laboratory results (检查检验结果互认). The purpose is to reduce unnecessary repeat testing while protecting clinical quality and safety.¹

The framework is real and has expanded substantially. But “mutual recognition” does not mean:

“Any result from any hospital must be accepted everywhere.”

For patients, the most useful way to understand the system is:

Recognition depends on the test, the participating institutions or region, quality-control status, timing, clinical relevance, available data, and the receiving physician's judgment.

That last factor is explicit in national policy.

What counts as a “test result” under the national rules?

China's 2022 national rules distinguish between:

• examination results: images or data from ultrasound, X-ray, MRI, electrophysiology, nuclear medicine, and similar examinations; and
• laboratory results: data from biological, microbiological, immunological, chemical, hematological, cellular, and related testing of human samples.²

The rules explicitly state that these “results” do not include a physician's diagnostic conclusion.²

That distinction matters. Another hospital may accept the underlying CT images or blood-test values while still forming its own diagnosis.

What is the “HR” mark?

The 2022 rules created a standardized recognition mark: HR.³

A result may be labeled with a recognition scope plus the HR mark, for example:

• national HR;
• a regional HR designation;
• a city/district HR designation.

The recognition scope depends on quality-control participation and qualification. Projects that meet national quality criteria and pass national quality evaluation can have nationwide recognition; regional projects may have recognition within the relevant quality-control region.³

If a result does not carry an HR mark, that does not automatically make it unusable. The national rules encourage clinicians, where clinically appropriate, to recognize other results as well.⁴ But the stronger formal recognition obligation applies to results that meet the applicable recognition conditions.

When should a Chinese hospital recognize a previous result?

Under the 2022 rules, medical institutions and clinicians should recognize eligible results carrying the appropriate national or regional recognition mark when doing so does not affect diagnosis or treatment.⁴

Where a patient's existing result meets the recognition conditions and is sufficient for the current clinical need, the institution and clinician should not repeat the test.⁵

This is the policy objective: reduce duplication without forcing a clinician to rely on a result that is no longer adequate.

The receiving doctor still has clinical discretion

China's 2024 national guidance continues to make the receiving physician's judgment a core part of the system. It states that mutual recognition should be built around quality and safety, clinical need, information infrastructure, patient convenience, and the judgment of the receiving physician.⁶

In a January 2025 National Health Commission briefing, officials described six broad situations in which repeat testing may be appropriate, including:

1. the patient's condition has changed and the old result no longer fits the clinical picture;
2. the relevant result can change quickly during disease progression;
3. the test is important before a major medical intervention such as surgery or transfusion;
4. the patient is in an emergency or urgent-care situation;
5. the test is needed for forensic, disability, or similar formal assessment;
6. other situations where the physician determines repeat testing is clinically necessary.⁷

For an international patient, this means a request to repeat a test is not automatically evidence of “non-recognition” or poor coordination. The key question is why the repeat test is required.

How far has mutual recognition actually progressed?

China has been expanding the system in stages.

The 2024 national guidance set targets including:

• by the end of 2025, more than 200 mutually recognized items within each prefecture-level city;
• by the end of 2027, more than 300 mutually recognized items within each province;
• by the end of 2027, more than 200 items across major cross-provincial regions such as Beijing–Tianjin–Hebei, the Yangtze River Delta, and Chengdu–Chongqing;
• by 2030, a more mature national system for common cross-region and cross-institution sharing and recognition.⁶

By December 2025, the National Health Commission reported that all provinces had achieved more than 200 mutually recognized items within prefecture-level cities, that 25 provinces had built provincial imaging-cloud systems, and that thousands of public hospitals and primary-care institutions had connected to regional platforms.⁸

The 2026 national health-service priorities continue to call for stronger regional information platforms, laboratory and radiology quality control, and greater standardization across secondary and higher-level hospitals.⁹

So the direction is clear: mutual recognition is becoming more systematic. But it remains project-, institution-, region-, and clinical-situation dependent.

A new 2026 laboratory-recognition standard is coming—but is not yet in force

The National Health Commission published the health-industry standard WS/T 885—2026, Basic Technical Conditions and Quality Indicators for Mutual Recognition of Clinical Laboratory Results, on May 25, 2026.¹⁰

Its effective date is November 1, 2026.¹⁰

As of CMI's last verification on September 9, 2026, the standard has been published but is not yet effective.

This is important because patients and providers may see the new standard cited in 2026 materials before its formal implementation date.

Does mutual recognition mean my MRI from another Chinese hospital will definitely be accepted?

No.

For imaging, the receiving hospital may need to know:

• when the scan was performed;
• whether the clinical condition has changed;
• whether the scan used the required protocol;
• whether contrast was used;
• whether the image quality is adequate;
• whether the original images are available;
• whether the study is within the applicable recognition scope;
• whether a new scan is needed for surgery, radiation planning, intervention, or another high-stakes decision.

A radiology report alone may not be sufficient for complex care. Bring the original DICOM images whenever possible. DICOM is the international standard for exchange and management of medical imaging information.¹¹

Does mutual recognition mean my blood tests will definitely be accepted?

No.

Laboratory values can change quickly, and different clinical decisions require different recency.

A blood count from several months ago may be useful history but irrelevant before surgery today. A stable genetic test may remain relevant for years. A tumor marker, electrolyte level, coagulation test, or kidney-function result may need to be repeated depending on treatment timing and clinical condition.

National policy therefore combines recognition with reference time limits, quality requirements, and clinical judgment rather than creating a universal expiration period for every test.⁶

What if my test was done outside China?

This is where international patients should be especially careful.

Fact

The formal HR framework is built around defined quality-control participation, recognition scopes, and designated recognition marks within China's medical system.³

CMI inference

An overseas report should not be assumed to fall automatically within China's HR mutual-recognition framework, because it will generally not carry a Chinese national or regional HR designation or participate in the same quality-control mechanism.

Practical implication

A Chinese physician may still use an overseas result if it is clinically credible and relevant. But acceptance is likely to depend on:

• the originating institution;
• report language;
• test method and reference range;
• date;
• image quality;
• availability of raw/original data;
• whether the result can be independently reviewed;
• whether the current decision requires a new examination.

Bring the most complete data possible.

What should I carry from one hospital to another?

For laboratory tests

Bring:

• original laboratory report;
• date and time of collection;
• units;
• reference ranges;
• testing method when shown;
• hospital/laboratory name;
• patient identifiers;
• trend data from previous tests where relevant.

National rules specifically encourage standardized reports and require laboratory reports used for recognition to indicate testing methods and reference intervals.¹²

For MRI / CT / PET / ultrasound

Bring:

• radiology report;
• original DICOM files where applicable;
• prior comparative examinations;
• contrast information if relevant;
• body part and protocol;
• date of study;
• hospital name.

For pathology

Bring:

• pathology report;
• immunohistochemistry or molecular results;
• pathology slides or digital pathology files if a second review is anticipated;
• block availability information if relevant.

Pathology review is a specialized process and should not be treated as identical to routine laboratory-result mutual recognition.

What to ask the receiving hospital

Instead of asking only:

“Do you accept outside results?”

Ask:

1. “Is this specific test on your mutual-recognition list?”
2. “Does the result need an HR mark?”
3. “Is there a time limit for this result?”
4. “Do you need the original images or only the report?”
5. “Can you access the study through the regional imaging platform?”
6. “If you need to repeat it, what is the clinical reason?”
7. “Can part of the previous work be accepted even if one component must be repeated?”

This produces a much more useful answer.

Why might two hospitals handle the same result differently?

Several reasons can be legitimate:

• different planned treatments;
• different clinical questions;
• different protocol requirements;
• different time since the test;
• change in symptoms or disease status;
• different participation in a mutual-recognition network;
• inability to access the original data;
• quality concerns;
• different local implementation rules;
• clinician judgment.

That variability is exactly why CMI does not label a hospital simply as “accepts outside tests: yes/no.” A more accurate database needs to record which results, under which conditions, through which system, and with what limitations.

CMI practical rule

For medical travel in China, assume:

A previous result may reduce repeat testing, but carry enough documentation to allow the next hospital to judge it.

The best way to improve portability is to leave every institution with:

• reports;
• raw/original data where relevant;
• correct identifiers;
• dates;
• test methods and reference ranges;
• English or Chinese translations when necessary;
• a short clinical timeline.

Frequently asked questions

Is mutual recognition a nationwide law?

China has national administrative rules and national policy guidance governing mutual recognition, with implementation carried out through national, provincial, regional, and institutional quality-control and information systems.¹⁶ It is more accurate to describe this as a national regulatory and policy framework than as a guarantee that every test is universally accepted.

What does “HR” mean on a report?

It is the standardized mutual-recognition mark used under the 2022 national rules. The report may also indicate the applicable recognition scope.³

Can a doctor refuse an HR-marked result?

The rules require recognition when the result meets the applicable conditions and is sufficient for diagnosis and treatment, but the physician can order a new test when clinical circumstances make the previous result inadequate.⁴⁷

If a hospital repeats my test, should I ask why?

Yes. Ask whether the reason is clinical change, timing, protocol, quality, treatment planning, emergency need, or lack of recognition eligibility.

Will regional image clouds solve the problem?

They improve access to images and reports, but access and technical sharing do not eliminate clinical judgment. The National Health Commission's 2025 reporting shows substantial expansion of provincial image-cloud infrastructure, while national policy continues to preserve physician discretion.⁸